Martínez TR, Zambada C, Álvarez GR, González VM, Yáñez C, Reyes E, Díaz A, Domínguez B

Language: Spanish
References: 11
Page: 184-190
PDF size: 55.17 Kb.

ABSTRACT

One of the main targets of pre-anesthesia medication is to relief anxiety of the patient who will be taken to a surgical procedure. The drug mainly used to aim this goal is midazolam, but this is not the only one which produces this effect. Another group of drugs which produces the same effect is the alpha 2 adrenergic receptors like dexmedetomidine which has anothers hemodynamical effects like a decrease in heart rate and arterial blood pressure. We take advantage of these effects to medicate patients whom were programmed for and endoscopic paranasal sinuses surgery during which, the infiltration with lidocaine with epinephrine increases both heart rate and blood pressure. We formed 2 groups with 20 patients each, one of the groups receiving dexmedetomidine as premedication and another group receiving midazolam. We assumed that patients receiving dexmedetomidine will not increase the heart rate or the blood pressure as much as the midazolam group. We found evidence that sustain our hypothesis and no adverse effects were found.

REFERENCES

1. Aanta R, Scheinin M. Alpha2-adrenergic agents in anaesthesia. Acta Anaesthesiol Scand 1993; 37: 433-448.

2. Maze M, Tranquilli W. Alpha-2 adrenoceptor agonists: Defining the role in clinical anesthesia. Anesthesiology 1991; 74: 581-605.

3. Riler R, Ramsay M, Richard P, Jorden V. Dexmedetomidine provides effective long-term sedation for intubated ICU patients when compared with midazolam: A randomized open-label pilot study. Chest 2001; 120 (4 suppl): 260S.

4. Brown D, Avramov M, Tuman K, Ivankovick A. The effect of dexmedetomidine on EEG-bispectral index. Anesthesia & Analgesia 1999; 88 (2S): 52S.

5. Maze M, Fujinaga M. [Alpha]2 adrenoceptors in pain modulation: Which subtype should be targeted to produce analgesia? Anesthesiology 2000; 92 (4): 934.

6. Kamibayashi T, Maze M. Clinical uses of [alpha]2-adrenergic agonists. Anesthesiology 2000; 93 (5): 1345-1349.

7. Aantaa R, Jaakola M, Kallio A, Scheinin M, Vuorinen J. A comparison of dexmedetomidine, an alpha 2-adrenoceptor agonist, and midazolam as i.m. premedication for minor gynaecological surgery. Br J Anaesth 1991; 67 (4): 402-409.

8. Hayashi Y, Maze M. Alpha2 adrenoceptor agonists and anaesthesia. Br J Anaesth 1993; 71: 108-118.

9. Shahbaz A, Thomas E. The efficacy, side effects, and recovery characteristics of dexmedetomidine versus propofol when used for intraoperative sedation. Anesthesia & Analgesia 2002; 95 (2): 461-466.

10. Nelson L, Lu J, Guo T, Saper C, Franks N, Maze M. The [alpha]2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-prompting pathway to exert its sedative effects. Anesthesiology 2003; 98 (2): 428-436.

11. Stoelting R. Pharmacology and physiology in anesthetic practice. 3th ed. Philadelphia, PA: Lippincott-Raven Publishers, 1999; 307.